These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 26505569

  • 1. Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
    Garcia-Amador M, Merchán-Naranjo J, Tapia C, Moreno C, Castro-Fornieles J, Baeza I, de la Serna E, Alda JA, Muñoz D, Andrés Nestares P, Cantarero CM, Arango C.
    J Clin Psychopharmacol; 2015 Dec; 35(6):686-93. PubMed ID: 26505569
    [Abstract] [Full Text] [Related]

  • 2. Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
    Carbon M, Kapoor S, Sheridan E, Al-Jadiri A, Azzo S, Sarkaria T, Kane JM, Saito E, Correll CU.
    J Am Acad Child Adolesc Psychiatry; 2015 Sep; 54(9):718-727.e3. PubMed ID: 26299293
    [Abstract] [Full Text] [Related]

  • 3. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM, Bossie CA, Zhu Y, Mao L, Lasser RA.
    Schizophr Res; 2005 Sep 15; 77(2-3):129-39. PubMed ID: 15913962
    [Abstract] [Full Text] [Related]

  • 4. Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients.
    Woerner MG, Correll CU, Alvir JM, Greenwald B, Delman H, Kane JM.
    Neuropsychopharmacology; 2011 Jul 15; 36(8):1738-46. PubMed ID: 21508932
    [Abstract] [Full Text] [Related]

  • 5. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
    Arango C, Giráldez M, Merchán-Naranjo J, Baeza I, Castro-Fornieles J, Alda JA, Martínez-Cantarero C, Moreno C, de Andrés P, Cuerda C, de la Serna E, Correll CU, Fraguas D, Parellada M.
    J Am Acad Child Adolesc Psychiatry; 2014 Nov 15; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I, IC-SOHO Study Group.
    J Clin Psychiatry; 2004 Mar 15; 65(3):312-21. PubMed ID: 15096069
    [Abstract] [Full Text] [Related]

  • 7. Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.
    Alda JA, Muñoz-Samons D, Tor J, Merchán-Naranjo J, Tapia-Casellas C, Baeza I, Calvo-Escalona R, Castro-Fornieles J, Martínez-Cantarero C, Andrés-Nestares P, Fernández-Avilés F, Arango C.
    J Child Adolesc Psychopharmacol; 2016 Jun 15; 26(5):449-57. PubMed ID: 26779966
    [Abstract] [Full Text] [Related]

  • 8. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M, Paya B, Moreno D, de la Serna E, Arango C.
    J Child Adolesc Psychopharmacol; 2008 Aug 15; 18(4):327-36. PubMed ID: 18759642
    [Abstract] [Full Text] [Related]

  • 9. Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics.
    Fraguas D, Merchán-Naranjo J, Laita P, Parellada M, Moreno D, Ruiz-Sancho A, Cifuentes A, Giráldez M, Arango C.
    J Clin Psychiatry; 2008 Jul 15; 69(7):1166-75. PubMed ID: 18588363
    [Abstract] [Full Text] [Related]

  • 10. Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study.
    Chyou TY, Nishtala R, Nishtala PS.
    Pharmacoepidemiol Drug Saf; 2020 Jun 15; 29(6):692-700. PubMed ID: 32301237
    [Abstract] [Full Text] [Related]

  • 11. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
    Torrent C, Martinez-Arán A, Daban C, Amann B, Balanzá-Martínez V, del Mar Bonnín C, Cruz N, Franco C, Tabarés-Seisdedos R, Vieta E.
    Compr Psychiatry; 2011 Jun 15; 52(6):613-22. PubMed ID: 21295774
    [Abstract] [Full Text] [Related]

  • 12. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV.
    J Clin Psychiatry; 2004 Jun 15; 65 Suppl 9():21-4. PubMed ID: 15189108
    [Abstract] [Full Text] [Related]

  • 13. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.
    Actas Esp Psiquiatr; 2003 Jun 15; 31(6):347-52. PubMed ID: 14639511
    [Abstract] [Full Text] [Related]

  • 14. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
    Peritogiannis V, Tsouli S.
    J Psychopharmacol; 2010 Jul 15; 24(7):1121-5. PubMed ID: 19395427
    [Abstract] [Full Text] [Related]

  • 15. Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.
    Al-Dhaher Z, Kapoor S, Saito E, Krakower S, David L, Ake T, Kane JM, Correll CU, Carbon M.
    J Child Adolesc Psychopharmacol; 2016 Jun 15; 26(5):458-70. PubMed ID: 27093218
    [Abstract] [Full Text] [Related]

  • 16. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 Jun 15; 59 Suppl 12():23-7. PubMed ID: 9766616
    [Abstract] [Full Text] [Related]

  • 17. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
    Marras C, Herrmann N, Anderson GM, Fischer HD, Wang X, Rochon PA.
    Am J Geriatr Pharmacother; 2012 Dec 15; 10(6):381-9. PubMed ID: 23217531
    [Abstract] [Full Text] [Related]

  • 18. Movement Disorders in Children and Adolescents Receiving Antipsychotic Pharmacotherapy: A Population-Based Study.
    Biscontri RG, Jha S, Collins DM, Bugden S, Katz LY, Alessi-Severini S.
    J Child Adolesc Psychopharmacol; 2017 Dec 15; 27(10):892-896. PubMed ID: 29091743
    [Abstract] [Full Text] [Related]

  • 19. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
    Bressan RA, Jones HM, Pilowsky LS.
    J Psychopharmacol; 2004 Mar 15; 18(1):124-7. PubMed ID: 15107196
    [Abstract] [Full Text] [Related]

  • 20. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
    Byerly MJ, Nakonezny PA, Bettcher BM, Carmody T, Fisher R, Rush AJ.
    Schizophr Res; 2006 Sep 15; 86(1-3):244-50. PubMed ID: 16730951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.